Strasbourg, France

Marc Van Reganmortel

This inventor holds 1 USPTO granted patent. Top assignee: Pasteur Sanofi Diagnostics. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Van Reganmortel. Retrieved from https://idiyas.com/inventor/marc-van-reganmortel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc Van Reganmortel: Innovator in Synthetic Peptides

Introduction

Marc Van Reganmortel is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides. His work has implications for various applications in diagnostics and therapeutics.

Latest Patents

Marc holds a patent for "Synthetic peptides of the conjugate of ubiquitin and H2A histone." This innovative patent showcases his expertise in peptide synthesis and its potential applications in medical research.

Career Highlights

Marc is currently employed at Pasteur Sanofi Diagnostics, where he continues to advance his research in synthetic peptides. His role at this esteemed company allows him to collaborate with other experts in the field and contribute to groundbreaking developments in diagnostics.

Collaborations

Throughout his career, Marc has worked alongside talented colleagues such as Serge Plaue and Sylviane Muller. These collaborations have enriched his research and fostered a dynamic environment for innovation.

Conclusion

Marc Van Reganmortel's contributions to the field of synthetic peptides highlight his role as a key innovator in biotechnology. His patent and ongoing work at Pasteur Sanofi Diagnostics reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…